MedTrace Logo

A Study of PTS for Patients With Solid Tumors

NCT03448211 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2018-04-05

No results posted yet for this study

Summary

The primary objective of this study is to determine the MTD of PTS following local and intratumoral injections over a treatment course of two 5-day cycles to patients with palpable advanced solid malignancies who have failed standard treatment.

Conditions

Interventions

DRUG

Para-toluenesulfonamide Injection (PTS)

Intratumoral injection

Sponsors & Collaborators

  • PTS International Inc.

    lead INDUSTRY

Principal Investigators

  • Nan-Shan Zhong · The First Affiliated Hospital of Guangzhou Medical University

Study Design

Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2019-05-01
Completion
2019-08-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03448211 on ClinicalTrials.gov